This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
Save the date for next year!
March 18–20, 2024 | Barcelona, Spain

Inhibitec Anticuerpos SL


Inhibitec is a biotech company with the mission to develop a novel therapeutic approach for the treatment of inflammatory chronic and autoimmune diseases. Inhibitec is a startup company with its foundation on the Spanish National Research Council (CSIC) and the University of Cantabria (UC). Our main goal is to position B101.37, a specific monoclonal antibody targeting BAMBI (BMP and Activin Membrane-Bound Inhibitor), as a new standard in the treatment of psoriasis and psoriatic arthritis (PsA).